Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | G6PD | P11413 | 1/20 | 0.42 |
| ▸ | CASP7 | P55210 | 1/20 | 0.42 |
| ▸ | CASP6 | P55212 | 1/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.37 |
| ▸ | RECQL | P46063 | 3/20 | 0.36 |
| ▸ | EGFR | P00533 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | FYN | P06241 | 2/20 | 0.36 |
| ▸ | MMP9 | P14780 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL144361 | 0.86 | ALDH1A1 (0.60) | ALDH1A1TDP1TSHRCA2G6PD | |
| SCHEMBL564062 | 0.86 | ESR1 (0.47) | ALDH1A1TDP1TSHRCA2G6PD | |
| SCHEMBL1639984 | 0.79 | TDP1 (0.42) | ALDH1A1TDP1TSHRCA2G6PD | |
| SCHEMBL8511558 | 0.79 | ALDH1A1 (0.39) | ALDH1A1TDP1TSHRCA2G6PD | |
| SCHEMBL30438488 | 0.78 | ESR1 (0.47) | ALDH1A1TDP1TSHRCA2G6PD | |
| SCHEMBL2438871 | 0.77 | G6PD (0.42) | ALDH1A1TDP1TSHRCA2G6PD | |
| SCHEMBL6754030 | 0.77 | G6PD (0.42) | ALDH1A1TDP1TSHRCA2G6PD | |
| SCHEMBL8512559 | 0.76 | CD44 (0.48) | ALDH1A1TDP1TSHRCA2CASP7 | |
| SCHEMBL986029 | 0.76 | CA2 (0.54) | ALDH1A1TDP1TSHRCA2TRPA1 | |
| SCHEMBL584830 | 0.75 | ALDH1A1 (0.71) | ALDH1A1TDP1TSHRCA2TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109311800-A | The manufacturing method and aforementioned Ppolynuclear aromatic aminophenol compound, resin combination and solidfied material of Ppolynuclear aromatic aminophenol compound and resin combination | DIC株式会社 | 2019-02-05 | — | — | CN | disclosed |
| US-8674029-B2 | Method of preparing stabilized polymeric systems using polymeric peroxides | Sunocs LLC (US) | 2014-03-18 | — | — | US | disclosed |
| US-20120035307-A1 | PROCESS FOR MAKING STABLIZED POLYMERIC SYSTEMS WITH NANOSTRUCTURES | SONG CHENGQIAN (US) | 2012-02-09 | — | — | US | disclosed |
| US-20120035315-A1 | METHOD OF PREPARING STABLIZED POLYMERIC SYSTEMS USING POLYMERIC PEROXIDES | SONG CHENGQIAN (US) | 2012-02-09 | — | — | US | disclosed |
| US-7498467-B2 | Antioxidant and bisaminophenol derivative | IDEMITSU KOSAN CO., LTD. (JP) | 2009-03-03 | — | — | US | disclosed |
| US-20080161608-A1 | ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE | IDEMITSU KOSAN CO., LTD. (JP) | 2008-07-03 | — | — | US | disclosed |
| US-20060208227-A1 | Antioxidant and bisaminophenol derivative | IDEMITSU LOSAN CO., LTD (JP) | 2006-09-21 | — | — | US | disclosed |
| EP-1612254-A1 | ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE | IDEMITSU KOSAN COMPANY LIMITED (JP) | 2006-01-04 | — | — | EP | disclosed |
| US-20040152862-A1 | Optical resins and applications thereof | HITACHI CHEMICAL CO., LTD. (JP) | 2004-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161608-A1 | ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE | CBR1, CBR3, HMOX1 | ALDH1A1 204/4885TDP1 1337/4885TSHR 2375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.